Saliva as a diagnostic medium

Biomedical Papers

Volumn 153, Issue 2, 2009, Pages 103-110

  Pink, Richard ^a   Simek, Jiri ^a   Vondrakova, Jana ^a   Faber, Edgar ^a   Michl, Petr ^a   Pazdera, Jindrich ^a   Indrak, Karel ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Saliva Biomarkers Diagnostics

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70149088159     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2009.017     Document Type: Review

References (55)

1. de Almeida Pdel V, Grégio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review J Contemp Dent pract. 2008 9 72-80.
2. Turner RJ. Mechanisms of fluid secretion by salivary glands. Ann. NY Acad. Sci 1993; 694:24-35.
3. Kassan SS, Moutsopoulos HM.Clinical manifestation and early diagnosis of Sjögren's syndrome. Arch. Intern. Med. 2004; 164: 1275-84.
4. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Arch. Intern. med. 1978; 89: 888-92.
5. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lym- phoma predictors. Ann. Rheum. Dis 2006; 65:796-803.
6. Vitali C, Bombardieri S, Jonsson R. The European Study Group on classification criteria for Sjögren's syndrome: a revised version of the American-European Consensus Group. Ann. Rheum. Dis 2002; 61: 554-8.
7. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic tool criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147-56.
8. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-en- hanced laser desorption ionization-time-of-flight-mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006; 45: 1077-86.
9. Boyle JO, Mao L, Brennan JA, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994; 168: 429-32.
10. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol 2002; 192: 52-7.
11. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rince screening of HPV for head and neck cancer. Int J Cancer 2005; 117: 605-10.
12. Smith EM, Ritchie JM, Summersgill KF, et al. Human papilloma- virus in oral exfoliated cells and ris of head and neck cancer 2004; 96: 449-55.
13. Negri L, Pacchioni D, Calabrese F, Giacomasso S, MastromatteoV, Fazio M. Serum and salivary CEA and GICA levels in oral cavity tumors. Int J Biol Markers 1988; 3: 107-12.
14. Mizukawa N, Sugiyama K, Fukunaga J, et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma pacients. Anticancer Res 1998; 18: 4645-9.
15. Hu S, Xie Y, Ramachandran P. Large- scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005 5 (6) 1714-1728.
16. St John M, Li Y, Zhou X et al. IL - 6 and IL8 potential biomarkers for oral cavity and oropharyngeal SCCA. Arch. Otolaryngol. Head Neck surg. 2004; 130: 929-935.
17. Streckfus CF, Bigler L, Dellinger TD, Dai X, Kingman A, Thigpen JT. The presence of c-erbB-2, and CA 15-3 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000; 6: 2363-2370.
18. Di-Xia C, Schwartz P, Fan-Qin L Salivary and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol 1990; 75: 701-704.
19. Wright DG, Meierovics AI, Foxley JM. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 1986; 67: 1023-1030.
20. Gorgun A, Knight DR, Wright GD. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy. American Journal of Hematology 2003; 72: 13-19.
21. Cheretakise C, Dror Y, Glogauer M. A non invasive oral rinse assay to monitor engraftment, neutrophil tissue delivery and susceptibil- ity to infection following HSCI in pediatric patients. Bone Marrow Transplantation 2005; 36: 227-232.
22. Lieschke GJ, Ramenghi U, O'Connor MP, Sheridan W, Szer J, Morstyn G. Studies of oral neutrophils levels in patients receiving G-CSF after autologous marrow transplantation. British Journal of Haematology 1992; 82: 589-595.
23. Gordis EB et. al. Asymmetry between salivary cortisol and alpha-amylase reactivity to stress: relation to aggresive behavior in ado- lescents. Psychoneu-roendocrinology 2006; 31: 976-987.
24. Chatterton RT et. al. Salivary alpha-amylase as a measure of endogenous adrenergic activity 1996; 16: 433-448.
25. Bosch JA et al. Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity. Psychosom. Med. 2003; 65: 245-58.
26. Beckett AH, Rowland M. Urinary excretion kinetics of ampheta- mine in man. J.Pharm. Pharmacol., 1965; 17: 628-638.
27. Wan SH, Matin SB, Azarnoff DL. Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH. Clin.Pharmacol. Ther. 1978; 23: 585-590.
28. Inaba T, Kalow W. Salivary excretion of amobarbital in man. Clin. Pharmacol.Ther. 1975; 18: 558-562.
29. Di-Gregorio GJ, Piraino AJ, Ruch E. Diazepam concetrations in parotid saliva, mixed saliva and plasma. Clin.Pharmacol.Ther. 1978; 24: 720-725.
30. Huestis MA, Cone EJ. Relationship of delta-9-tetrahydrocannabinol in oral fluid to plasma after controlled administration of smoked cannabis.J.Anal.Toxicol.2004; 28: 394-399.
31. Niedbala RS, Kardos KW, Salamone S. et al. Passive cannabis smoke exposure and oral fluid testing, J.Anal.Toxicol., 2004; 28: 546-552.
32. Niedbala RS, Kardos KW, Fritch EF et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle J.Anal.Toxicol. 2005; 29: 607-615.
33. Cone EJ, Oyler J, Darwin WD. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J. Anal. Toxicol. 1997; 21: 465-475.
34. Ëtzel RA. A review OF the use OF saliva conitine as a marker OF tobacco smoke exposure Prev.Med.1990; 19: 190-197.
35. Rook EJ, Van Ree JM, Van Den BW et al. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic.Clin.Pharmacol. Toxicol. 2006; 98: 86-96.
36. Jenkins AJ, Oyler JM, Cone EJ. Comparison of heroin and cocaine concetrations in saliva with concentrations in blood and plasma. J.Anal.Toxicol. 1995; 19: 359-374.
37. Cone EJ, Dickerson S, Paul BD, Mitchell JM, Forensic drug testing for opiates V.Urine testing for heroin, morphine, and codeine, with commercial opiate immunoassays. J.Anal.Toxicol. 1993; 17: 156-164.
38. Cone EJ. Saliva testing for drug abuse. Ann.N.Y.Acad.Sci. 1993; 694: 91-127.
39. Jenkins AJ, Oyler JM, Cone EJ. Comparison of heroin and cocain concentrations in saliva with concentration in blood and plasma J.Anal.Toxicol, 1995; 19: 359-374.
40. Rohrig TP, Moore C. The determination of morphine in urine and oral fluid following ingestion of poppy seeds J.Anal.Toxikol. 2003; 27: 449-452.
41. Kim I, Barnes AJ, Oyler JM et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration Clin.Chem. 2000; 48: 1486-1496.
42. Eguchi J, Isihara K, Watanabe A, Fukumoto Y, Okuda K. PCR method is essential for detecting Mycobacterium tuberculosis in oral cavity samples. Oral.Microbiol.Immunol. 2003; 18(3): 156-159.
43. Shames B, Krajden S, Fuksa M, Babida C, Penner JL. Evidence for the occurence of the same strain of Campylobacter pylori in the stomach and dental plaque. J.Clin.Microbiol., 1989; 27(12): 2849-2850.
44. Tiwari SK, Khan AA, Ahmed KS et al. Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach. Singapore Med.J. 2005; 46(5): 224-228.
45. Granstrom G, Askelof P, Granstrom M. Specific immunoglobulin A to Bordetella pertussis antigens in mucosal secretion for rapid diagnosis of whooping cough. J.Clin.Microbiol., 1988; 26(5): 869-874.
46. Scully C. HIV topic update: salivary testing for antibodies, Oral. Dis.,1997; 3: 212-215.
47. Martinez PM, Torres AR, Ortiz de Lejarazu R, Montoya A, Martin JF, Eiros JM. HIV antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival -crevicular transu- date, and urine samples. J.Clin.Microbiol. 1999; 37: 1100-1106.
48. Grant RM, Piwowar EM, Katongole-Mbidde E et al. Com parison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay. Clin. Diag.Laboratory Immunol. 1996; 3: 640-644.
49. Luizzi G, Chirianni A, Clementi M, Zaccarelli M, Antinori A, Piazza M. Reduction of HIV-1 viral load in saliva by indinavircontaining antiretroviral regimen. 2002; 16(3): 503-504.
50. Baron S, Poast J, Cloyd MW. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch.Intern.Med., 1999; 159 (3): 303-310.
51. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 anti- gen specific assays? J.Virol. Methods 2007; 143(1): 86-94.
52. Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. Human herpesvirus 8 detection in nasal secretion and saliva J.Infect. Dis. 1998; 177: 213-216.
53. LaDuca JR, Love JL, Abott LZ, Dube S, Freidman-Kien AE, Poiesz BJ, Detestion OF human herpes virus 8 DNA sequences in tissues and bodily fluids. J.Infect. Dis. 1998; 178: 1610-1615.
54. Crepin P, Audry L, Rotivel Y, Gacoin A, Caroff C, Bourhy H. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J.Clin.Microbiol. 1998; 36: 1117-1121.
55. Crowcroft NS, Vyse A, Brown DW, Strachan DP. Epidemiology of Eppstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J.Epidemiol. Community Health, 1998; 52: 101-104.